HomeCompareVTHRX vs JNJ

VTHRX vs JNJ: Dividend Comparison 2026

VTHRX yields 4.15% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VTHRX wins by $6.2K in total portfolio value
10 years
VTHRX
VTHRX
● Live price
4.15%
Share price
$41.15
Annual div
$1.71
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.2K
Annual income
$541.06
Full VTHRX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — VTHRX vs JNJ

📍 VTHRX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVTHRXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VTHRX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VTHRX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VTHRX
Annual income on $10K today (after 15% tax)
$352.46/yr
After 10yr DRIP, annual income (after tax)
$459.90/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $243.71/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VTHRX + JNJ for your $10,000?

VTHRX: 50%JNJ: 50%
100% JNJ50/50100% VTHRX
Portfolio after 10yr
$23.1K
Annual income
$684.42/yr
Blended yield
2.96%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

VTHRX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VTHRX buys
0
JNJ buys
0
No recent congressional trades found for VTHRX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVTHRXJNJ
Forward yield4.15%3.36%
Annual dividend / share$1.71$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$26.2K$20.0K
Annual income after 10y$541.06$827.78
Total dividends collected$4.8K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: VTHRX vs JNJ ($10,000, DRIP)

YearVTHRX PortfolioVTHRX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,115$414.66$10,676$355.77+$439.00VTHRX
2$12,323$430.73$11,407$389.39+$916.00VTHRX
3$13,632$446.33$12,198$426.53+$1.4KVTHRX
4$15,048$461.44$13,056$467.62+$2.0KVTHRX
5$16,577$476.04$13,987$513.12+$2.6KVTHRX
6$18,228$490.11$14,998$563.56+$3.2KVTHRX
7$20,008$503.65$16,098$619.52+$3.9KVTHRX
8$21,925$516.66$17,295$681.69+$4.6KVTHRX
9$23,989$529.13$18,599$750.82+$5.4KVTHRX
10$26,209$541.06$20,022$827.78+$6.2KVTHRX

VTHRX vs JNJ: Complete Analysis 2026

VTHRXStock

Vanguard Target Retirement Funds offer a diversified portfolio within a single fund that adjusts its underlying asset mix over time. The funds provide broad diversification while incrementally decreasing exposure to stocks and increasing exposure to bonds as each fund’s target retirement date approaches. The funds continue to adjust for approximately seven years after that date until their allocations match that of the Target Retirement Income Fund. Investors in the funds should be able to tolerate the risks that come from the volatility of the stock and bond markets. You may wish to consider this fund if you’re planning to retire between 2028 and 2032.

Full VTHRX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this VTHRX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VTHRX vs SCHDVTHRX vs JEPIVTHRX vs OVTHRX vs KOVTHRX vs MAINVTHRX vs ABBVVTHRX vs MRKVTHRX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.